Market closed
Alvotech/$ALVO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.
Ticker
$ALVO
Sector
Trading on
Industry
Biotechnology
Headquarters
Luxembourg, Luxembourg
Employees
999
Website
Alvotech Metrics
BasicAdvanced
$3.5B
-
-$1.74
-0.10
-
Price and volume
Market cap
$3.5B
Beta
-0.1
52-week high
$15.04
52-week low
$9.15
Average daily volume
115K
Financial strength
Current ratio
2.695
Quick ratio
1.644
Long term debt to equity
-333.628
Total debt to equity
-343.462
Interest coverage (TTM)
-0.07%
Management effectiveness
Return on assets (TTM)
-1.04%
Return on equity (TTM)
87.89%
Valuation
Price to revenue (TTM)
7.431
Price to book
-9.45
Price to tangible book (TTM)
-8.63
Price to free cash flow (TTM)
-9.718
Growth
Revenue change (TTM)
517.92%
Earnings per share change (TTM)
-34.54%
Alvotech News
AllArticlesVideos
Alvotech Acquires Xbrane's R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production
GlobeNewsWire·3 days ago
Alvotech Acquires Xbrane's R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production
GlobeNewsWire·3 days ago
Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Alvotech stock?
Alvotech (ALVO) has a market cap of $3.5B as of March 23, 2025.
What is the P/E ratio for Alvotech stock?
The price to earnings (P/E) ratio for Alvotech (ALVO) stock is 0 as of March 23, 2025.
Does Alvotech stock pay dividends?
No, Alvotech (ALVO) stock does not pay dividends to its shareholders as of March 23, 2025.
When is the next Alvotech dividend payment date?
Alvotech (ALVO) stock does not pay dividends to its shareholders.
What is the beta indicator for Alvotech?
Alvotech (ALVO) has a beta rating of -0.1. This means that it has an inverse relation to market volatility.